AnPac Bio-Medical Science Co., Ltd. Total Non Current Liabilities 2011-2026 | ANPC

Annual Total Non Current Liabilities AnPac Bio-Medical Science Co., Ltd.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	3.09 M	2.71 M	3.72 M	15.3 M	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
15.3 M	2.71 M	6.2 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 9.13	-0.76 %	$ 591 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	131 M	-	-	$ 866 M	China
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.91	2.42 %	$ 6.69 M	China
Edesa Biotech EDSA	2.6 M	$ 15.52	-2.39 %	$ 49.6 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 22.47	1.19 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Fortress Biotech FBIO	83.9 M	$ 2.24	0.9 %	$ 62.5 M	USA
Galectin Therapeutics GALT	52 K	$ 2.26	0.22 %	$ 144 M	USA
Galapagos NV GLPG	2.41 B	$ 28.07	0.75 %	$ 2.69 B	Belgium
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	7.22 B	$ 8.2	3.6 %	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	149 M	$ 31.01	-0.13 %	$ 1.78 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
ImmuCell Corporation ICCC	11.5 M	$ 8.44	-	$ 76.2 M	USA
InflaRx N.V. IFRX	254 K	$ 1.95	-1.77 %	$ 152 M	Germany
Immuron Limited IMRN	175 K	$ 0.83	3.44 %	$ 6.55 M	Australia
Incyte Corporation INCY	315 M	$ 98.87	-0.23 %	$ 19.3 B	USA
InMed Pharmaceuticals INM	338 K	$ 0.71	1.28 %	$ 1.74 M	Canada
INmune Bio INMB	126 K	$ 1.35	1.5 %	$ 33.4 M	USA
Innoviva INVA	377 M	$ 23.13	0.35 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	341 M	$ 104.54	2.92 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Jaguar Health JAGX	10.3 M	$ 7.55	-4.13 %	$ 17.6 M	USA
KalVista Pharmaceuticals KALV	5.05 M	$ 26.67	-0.02 %	$ 1.44 B	Britain
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	105 M	$ 1.43	-4.03 %	$ 235 M	France
Kamada Ltd. KMDA	7.06 M	$ 8.15	0.49 %	$ 260 M	Israel
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Kazia Therapeutics Limited KZIA	11.6 M	$ 13.24	6.56 %	$ 1.75 B	Australia
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ligand Pharmaceuticals Incorporated LGND	711 M	$ 223.98	-0.39 %	$ 4.1 B	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.22	7.69 %	$ 5.3 M	Israel
Liquidia Corporation LQDA	10.3 M	$ 38.39	0.62 %	$ 3.3 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	90.3 M	$ 4.08	0.74 %	$ 436 M	USA